VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
VBI Vaccines reports 2022 executive compensation
By ExecPay News
Published: May 1, 2023
VBI Vaccines reported fiscal year 2022 executive compensation information on May 1, 2023.
In 2022, three executives at VBI Vaccines received on average a compensation package of $1.3M, a 46% decrease compared to previous year.
Average pay of disclosed executives at VBI Vaccines
Jeffrey R. Baxter, Chief Executive Officer, received $1.8M in total, which decreased by 47% compared to 2021. 50% of Baxter's compensation, or $922K, was in option awards. Baxter also received $163K in bonus, $678K in salary, as well as $68K in other compensation.
Francisco Diaz-Mitoma, Chief Medical Officer, received a compensation package of $1M, which decreased by 46% compared to previous year. 46% of the compensation package, or $461K, was in salary.
David E. Anderson, Chief Scientific Officer, earned $995K in 2022, a 45% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on May 1, 2023.